Crm1 Inhibitory and Antiproliferative Activities of Novel 4'-alkyl Substituted Klavuzon Derivatives

dc.contributor.author Kanbur, Tuğçe
dc.contributor.author Kara, Murat
dc.contributor.author Kutluer, Meltem
dc.contributor.author Şen, Ayhan
dc.contributor.author Delman, Murat
dc.contributor.author Alkan, Aylin
dc.contributor.author Otaş, Hasan Ozan
dc.contributor.author Akçok, İsmail
dc.contributor.author Çağır, Ali
dc.coverage.doi 10.1016/j.bmc.2017.06.030
dc.date.accessioned 2017-10-03T07:49:33Z
dc.date.available 2017-10-03T07:49:33Z
dc.date.issued 2017
dc.description.abstract Klavuzons are 6-(naphthalen-1-yl) substituted 5,6-dihydro-2H-pyran-2-one derivatives showing promising antiproliferative activities in variety of cancer cell lines. In this work, racemic syntheses of nine novel 4′-alkyl substituted klavuzon derivatives were completed in eight steps and anticancer properties of these compounds were evaluated. It is found that size of the substituent has dramatic effect over the potency and selectivity of the cytotoxic activity in cancerous and healthy pancreatic cell lines. The size of the substituent can also effect the CRM1 inhibitory properties of klavuzon derivatives. Strong cytotoxic activity and CRM1 inhibition can be observed only when a small substituent present at 4′-position of naphthalen-1-yl group. However, these substituents makes the molecule more cytotoxic in healthy pancreatic cells rather than cancerous pancreatic cells. Among the tested compounds 1,2,3,4-tetrahydrophenanthren-9-yl substituted lactone was the most cytotoxic compound and its antiproliferative activity was also tested in 3D spheroids generated from HuH-7 cell lines. en_US
dc.description.sponsorship Scientific and Technological Research Council of Turkey (TUBITAK 113Z146) en_US
dc.identifier.citation Kanbur, T., Kara, M., Kutluer, M., Şen, A., Delman, M., Alkan, A., Otaş, H. O., Akçok, İ., and Çağır, A. (2017). CRM1 inhibitory and antiproliferative activities of novel 4′-alkyl substituted klavuzon derivatives. Bioorganic and Medicinal Chemistry, 25(16), 4444-4451. doi:10.1016/j.bmc.2017.06.030 en_US
dc.identifier.doi 10.1016/j.bmc.2017.06.030
dc.identifier.doi 10.1016/j.bmc.2017.06.030 en_US
dc.identifier.issn 0968-0896
dc.identifier.scopus 2-s2.0-85021812033
dc.identifier.uri http://doi.org/10.1016/j.bmc.2017.06.030
dc.identifier.uri https://hdl.handle.net/11147/6296
dc.language.iso en en_US
dc.publisher Elsevier Ltd. en_US
dc.relation info:eu-repo/grantAgreement/TUBITAK/KBAG/113Z146 en_US
dc.relation.ispartof Bioorganic and Medicinal Chemistry en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject CRM1 inhibition en_US
dc.subject Hepatocellular carcinoma en_US
dc.subject Klavuzon en_US
dc.subject Pancreatic cancer en_US
dc.subject Antiproliferative activity en_US
dc.subject 3D cell culture en_US
dc.title Crm1 Inhibitory and Antiproliferative Activities of Novel 4'-alkyl Substituted Klavuzon Derivatives en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.institutional Kanbur, Tuğçe
gdc.author.institutional Kara, Murat
gdc.author.institutional Kutluer, Meltem
gdc.author.institutional Şen, Ayhan
gdc.author.institutional Delman, Murat
gdc.author.institutional Alkan, Aylin
gdc.author.institutional Otaş, Hasan Ozan
gdc.author.institutional Akçok, İsmail
gdc.author.institutional Çağır, Ali
gdc.author.yokid 106911
gdc.author.yokid 115275
gdc.author.yokid 110975
gdc.bip.impulseclass C4
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology. Chemistry en_US
gdc.description.endpage 4451 en_US
gdc.description.issue 16 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 4444 en_US
gdc.description.volume 25 en_US
gdc.description.wosquality Q1
gdc.identifier.openalex W2648874330
gdc.identifier.pmid 28689976
gdc.identifier.wos WOS:000406023000022
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.accesstype BRONZE
gdc.oaire.diamondjournal false
gdc.oaire.downloads 0
gdc.oaire.impulse 7.0
gdc.oaire.influence 2.8533405E-9
gdc.oaire.isgreen true
gdc.oaire.keywords 3D cell culture
gdc.oaire.keywords Dose-Response Relationship, Drug
gdc.oaire.keywords Molecular Structure
gdc.oaire.keywords Hepatocellular carcinoma
gdc.oaire.keywords Klavuzon
gdc.oaire.keywords Receptors, Cytoplasmic and Nuclear
gdc.oaire.keywords Antineoplastic Agents
gdc.oaire.keywords Exportin 1 Protein
gdc.oaire.keywords Pancreatic cancer
gdc.oaire.keywords Antiproliferative activity
gdc.oaire.keywords Karyopherins
gdc.oaire.keywords Naphthalenes
gdc.oaire.keywords Structure-Activity Relationship
gdc.oaire.keywords CRM1 inhibition
gdc.oaire.keywords Tumor Cells, Cultured
gdc.oaire.keywords Humans
gdc.oaire.keywords Drug Screening Assays, Antitumor
gdc.oaire.keywords Cell Proliferation
gdc.oaire.keywords Pyrans
gdc.oaire.popularity 3.1740204E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 01 natural sciences
gdc.oaire.sciencefields 0104 chemical sciences
gdc.oaire.views 5
gdc.openalex.collaboration National
gdc.openalex.fwci 1.5511733
gdc.openalex.normalizedpercentile 0.73
gdc.opencitations.count 8
gdc.plumx.crossrefcites 9
gdc.plumx.mendeley 13
gdc.plumx.patentfamcites 1
gdc.plumx.pubmedcites 3
gdc.plumx.scopuscites 9
gdc.scopus.citedcount 9
gdc.wos.citedcount 8
relation.isAuthorOfPublication.latestForDiscovery 95611ee0-9a5b-4ec8-90ea-22896ec18aa9
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4011-8abe-a4dfe192da5e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Name:
6296.pdf
Size:
1.72 MB
Format:
Adobe Portable Document Format
Description:
Makale

License bundle

Now showing 1 - 1 of 1
Loading...
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: